PMID: 11320028Apr 26, 2001Paper

Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project

Ophthalmology
M R VanNewkirkHugh R Taylor

Abstract

To study the cause-specific prevalence of eye diseases causing bilateral visual impairment in Australian adults. Two-site, population-based cross-sectional study. Participants were aged 40 years and older and resident in their homes at the time of recruitment for the study. The study was conducted during 1992 through 1996. The study uses a cluster stratified random sample of 4744 participants from two cohorts, urban, and rural Victoria. Participants completed a standardized interview and eye examination, including presenting and best-corrected visual acuity, visual fields, and dilated ocular examination. The major cause of vision loss was identified for all participants found to be visually impaired. Population-based prevalence estimates are weighted to reflect the age and gender distribution of the two cohorts in Victoria. Visual impairment was defined by four levels of severity on the basis of best-corrected visual acuity or visual field: <6/18 > or =6/60 and/or <20 degrees > or =10 degrees radius field, moderate vision impairment; severe vision impairment, <6/60 > or =3/60 and/or <10 degrees > or =5 degrees radius field; and profound vision impairment <3/60 and/or <5 degrees radius field. In addition, less-than-legal driving...Continue Reading

References

Nov 14, 1991·The New England Journal of Medicine·A SommerS Ezrine
Aug 1, 1991·Ophthalmology·R KleinD L De Mets
Nov 14, 1990·JAMA : the Journal of the American Medical Association·M R DanaH R Taylor
Feb 1, 1990·Archives of Ophthalmology·J M TielschR M Royall
Jan 1, 1989·Archives of Ophthalmology·A HeijlJ Olsson
Dec 1, 1988·The New England Journal of Medicine·H R TaylorE A Emmett
Jun 15, 1984·Documenta Ophthalmologica. Advances in Ophthalmology·E Wagner
May 1, 1980·Survey of Ophthalmology·D E KreugerL R Maunder
Feb 1, 1994·Ophthalmology·P R Lichter
Dec 1, 1994·Ophthalmic Epidemiology·P M LivingstonH R Taylor
Jun 1, 1996·Ophthalmic Epidemiology·H S NewlandS Obermeder
Apr 17, 1998·Ophthalmology·M D WensorH R Taylor
Feb 17, 2000·Archives of Ophthalmology·L M WeihH R Taylor

❮ Previous
Next ❯

Citations

Jul 24, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Vinay NangiaRajesh Gupta
Sep 24, 2010·International Ophthalmology·Ian Yat Hin WongClement Wai Nang Chan
Jun 13, 2003·Clinical Cornerstone·Susan Lightman, Hamish M Towler
Sep 6, 2002·Clinical & Experimental Ophthalmology·Jie Jin Wang, Mark C Gillies
Dec 6, 2011·Global Public Health·Adam GordoisKathleen Chua
Sep 21, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Ferdinand ZiziOneca Heath-Phillip
Dec 4, 2004·International Ophthalmology Clinics·Rubin W Kim, Jeffrey S Heier
May 29, 2003·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Gerardo M VillarrealJesus H Mohamed
Oct 9, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Rod D Watkins
Oct 9, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Tim CF LoErica L Fletcher
Jul 24, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Barry L Cole
May 19, 2004·The British Journal of Ophthalmology·A FotouhiUNKNOWN Tehran Eye Study
Aug 23, 2005·The British Journal of Ophthalmology·L XuJ B Jonas
Mar 21, 2006·The British Journal of Ophthalmology·L VijayaC McCarty
Dec 6, 2001·The British Journal of Ophthalmology·R Dandona, L Dandona
Feb 25, 2003·The British Journal of Ophthalmology·C G OwenA R Rudnicka
Jul 6, 2002·BMJ : British Medical Journal·Hugh R TaylorJohn J McNeil
Oct 20, 2007·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Guy Donati
Sep 17, 2005·The Journal of Clinical Investigation·Takeshi YoshidaIkuo Morita
Jul 16, 2003·BMC Ophthalmology·Hassan HashemiKazem Mohammad
Mar 17, 2006·BMC Medicine·Lalit Dandona, Rakhi Dandona
Apr 27, 2013·Indian Journal of Ophthalmology·Lingam VijayaSathyamangalam Ve Ramesh
Jul 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yutaka ImamuraKazuo Tsubota
Sep 27, 2007·Ophthalmic Epidemiology·Ronald Klein
Jan 20, 2016·The Australian Journal of Rural Health·Hessom RazaviAngus Warwick Turner
Jan 1, 2013·Journal of the American Medical Directors Association·Estefania ChriquiHélène Kergoat
May 31, 2011·Journal of the American Medical Directors Association·Tanguy BoutinHélène Kergoat
Oct 26, 2010·American Journal of Ophthalmology·Ya Xing WangJost B Jonas
Jun 9, 2009·Ophthalmology·Anselm J HennisUNKNOWN Barbados Eye Studies Group
Feb 5, 2008·Ophthalmology·Akira SawadaUNKNOWN Tajimi Study Group
Jan 27, 2005·Diabetes & Metabolism·F HarzallahH Slimane
Dec 26, 2006·American Journal of Ophthalmology·Hugh R Taylor
Nov 1, 2005·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Josephine BattistaAndrew Metha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.